anti ngf prongf  (Alomone Labs)


Bioz Verified Symbol Alomone Labs is a verified supplier
Bioz Manufacturer Symbol Alomone Labs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 92

    Structured Review

    Alomone Labs anti ngf prongf
    Anti Ngf Prongf, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti ngf prongf/product/Alomone Labs
    Average 92 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti ngf prongf - by Bioz Stars, 2022-10
    92/100 stars

    Images

    Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94
    Alomone Labs anti prongf
    <t>proNGF</t> expression in nevi, primary melanoma and metastatic human tissues ( A – F ). Immunohistochemical detection of proNGF, representative pictures are shown for compound nevi ( A ), dysplastic nevi ( B ), thin primary melanomas ( C ), thick primary melanomas ( D ), lymph node metastases ( E ) and distant metastases ( F ). ( G ) Digital quantification of proNGF staining intensities according to grouped pathological subtypes: nevi (h-score = 156.2, IQR 138.9–176.1), primary melanomas (h-score = 129.0, IQR 111.8–1148.1) and metastases (h-score = 115.1, IQR 93.33–130.1). ( H ) proNGF staining intensities for individual pathological subtypes: CN = compound nevi (h-score = 143.4, IQR 126.1–176.0), DN = dysplastic nevi (h-score = 158.6, IQR 143.0–189.6), TnP = thin primary (h-score = 125.3, IQR 111.8–134.6), TkP = thick primary (h-score = 133.6, IQR 109.2–154.1), LNM = lymph node metastasis (h-score = 116.7, IQR 105.9–132.3), DM = distant metastasis (h-score = 101.8, IQR 91.64–129.7). ( I ) Correlation of proNGF and NGF stain intensities. Scale bar = 90 µm. Data are expressed as medians (horizontal line in the center of the box) and box limits indicate the interquartile range (IQR) with the whiskers extending 1.5 times the IQR from the 25th and 75th percentiles; outliers are represented by dots. H-score distributions were compared using the Wilcoxon rank-sum (dichotomous) or Kruskal–Wallis (multiple comparisons) tests ( p
    Anti Prongf, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti prongf/product/Alomone Labs
    Average 94 stars, based on 2 article reviews
    Price from $9.99 to $1999.99
    anti prongf - by Bioz Stars, 2022-10
    94/100 stars
      Buy from Supplier

    Image Search Results


    proNGF expression in nevi, primary melanoma and metastatic human tissues ( A – F ). Immunohistochemical detection of proNGF, representative pictures are shown for compound nevi ( A ), dysplastic nevi ( B ), thin primary melanomas ( C ), thick primary melanomas ( D ), lymph node metastases ( E ) and distant metastases ( F ). ( G ) Digital quantification of proNGF staining intensities according to grouped pathological subtypes: nevi (h-score = 156.2, IQR 138.9–176.1), primary melanomas (h-score = 129.0, IQR 111.8–1148.1) and metastases (h-score = 115.1, IQR 93.33–130.1). ( H ) proNGF staining intensities for individual pathological subtypes: CN = compound nevi (h-score = 143.4, IQR 126.1–176.0), DN = dysplastic nevi (h-score = 158.6, IQR 143.0–189.6), TnP = thin primary (h-score = 125.3, IQR 111.8–134.6), TkP = thick primary (h-score = 133.6, IQR 109.2–154.1), LNM = lymph node metastasis (h-score = 116.7, IQR 105.9–132.3), DM = distant metastasis (h-score = 101.8, IQR 91.64–129.7). ( I ) Correlation of proNGF and NGF stain intensities. Scale bar = 90 µm. Data are expressed as medians (horizontal line in the center of the box) and box limits indicate the interquartile range (IQR) with the whiskers extending 1.5 times the IQR from the 25th and 75th percentiles; outliers are represented by dots. H-score distributions were compared using the Wilcoxon rank-sum (dichotomous) or Kruskal–Wallis (multiple comparisons) tests ( p

    Journal: International Journal of Molecular Sciences

    Article Title: Expression of NGF/proNGF and Their Receptors TrkA, p75NTR and Sortilin in Melanoma

    doi: 10.3390/ijms23084260

    Figure Lengend Snippet: proNGF expression in nevi, primary melanoma and metastatic human tissues ( A – F ). Immunohistochemical detection of proNGF, representative pictures are shown for compound nevi ( A ), dysplastic nevi ( B ), thin primary melanomas ( C ), thick primary melanomas ( D ), lymph node metastases ( E ) and distant metastases ( F ). ( G ) Digital quantification of proNGF staining intensities according to grouped pathological subtypes: nevi (h-score = 156.2, IQR 138.9–176.1), primary melanomas (h-score = 129.0, IQR 111.8–1148.1) and metastases (h-score = 115.1, IQR 93.33–130.1). ( H ) proNGF staining intensities for individual pathological subtypes: CN = compound nevi (h-score = 143.4, IQR 126.1–176.0), DN = dysplastic nevi (h-score = 158.6, IQR 143.0–189.6), TnP = thin primary (h-score = 125.3, IQR 111.8–134.6), TkP = thick primary (h-score = 133.6, IQR 109.2–154.1), LNM = lymph node metastasis (h-score = 116.7, IQR 105.9–132.3), DM = distant metastasis (h-score = 101.8, IQR 91.64–129.7). ( I ) Correlation of proNGF and NGF stain intensities. Scale bar = 90 µm. Data are expressed as medians (horizontal line in the center of the box) and box limits indicate the interquartile range (IQR) with the whiskers extending 1.5 times the IQR from the 25th and 75th percentiles; outliers are represented by dots. H-score distributions were compared using the Wilcoxon rank-sum (dichotomous) or Kruskal–Wallis (multiple comparisons) tests ( p

    Article Snippet: The following primary antibodies were applied: anti-proNGF (0.8 µg/mL, catalogue number ANT005, Alomone labs, Jerusalem, Israel), anti-NGF (13.3 µg/mL, catalogue number ab52918, Abcam, VIC, Australia), anti-sortilin (0.8 µg/mL, catalogue number ANT009, Alomone labs, Jerusalem, Israel), anti-p75NTR (2 µg/mL, catalogue number ANT007, Alomone labs, Jerusalem, Israel), anti-TrkA (1:200 dilution, catalogue number cs-2508, Cell Signaling Technology, Danvers, MA, USA).

    Techniques: Expressing, Immunohistochemistry, Staining

    Deletion of p75 NTR eliminates the diabetes-induced imbalance in proNGF and NGF expression. ( a ) Representative blots and statistical analysis of proNGF and ( b ) NGF protein levels in retinas of WT control (WTC), WT diabetic (WTD), HOC and HOD mice after

    Journal: Diabetologia

    Article Title: Modulation of p75NTR prevents diabetes- and proNGF-induced retinal inflammation and blood–retina barrier breakdown in mice and rats

    doi: 10.1007/s00125-013-2998-6

    Figure Lengend Snippet: Deletion of p75 NTR eliminates the diabetes-induced imbalance in proNGF and NGF expression. ( a ) Representative blots and statistical analysis of proNGF and ( b ) NGF protein levels in retinas of WT control (WTC), WT diabetic (WTD), HOC and HOD mice after

    Article Snippet: The following primary antibodies were used: polyclonal anti-NGF and anti-proNGF (Alomone Labs, Jerusalem, Israel); polyclonal anti-p75NTR (catalogue number 07–476), polyclonal anti-vascular endothelial growth factor (VEGF) and monoclonal anti-GFP antibody (Millipore, Billerica, MA, USA); monoclonal anti-TNF-α, polyclonal anti-IL-1β and polyclonal anti-sortilin (Abcam, Cambridge, MA, USA); monoclonal IgG2 (R & D Systems, Minneapolis, MN, USA); polyclonal anti-glial fibrillary acidic protein (GFAP) and monoclonal anti-vimentin (Thermo Fisher); polyclonal β-actin (Sigma-Aldrich, St Louis, MO, USA); monoclonal anti-brain-specific homeobox/POU domain protein 3A (BRN3A) and polyclonal anti-NFκB-p65 (Santa Cruz Biotechnology, Santa Cruz, CA, USA); and monoclonal anti-phospho-NFκB (p65 subunit) (Cell Signaling, Danvers, MA, USA).

    Techniques: Expressing, Mouse Assay

    SPR analysis—calibration curves obtained with proNGF and NGF over the panel of different antibodies. (A) Different proNGF concentrations tested on anti-proNGF mAb FPro10. Concentrations in nM (from top): 500, 333, 222, 148, 98, 65, 33, 16, 8, 4, 2, 1, 0.5; (B) Different proNGF concentrations tested on anti-proNGF mAb Millipore. Concentrations in nM (from top): 500, 333, 222, 148, 98, 65, 33, 16, 8, 4, 2, 1, 0.5; (C) Different proNGF concentrations tested on anti-NGF mAb αD11. Concentrations in nM (from top): 500, 333, 222, 148, 98, 65, 33, 16, 8, 4, 2, 1, 0.5; (D) Different proNGF concentrations tested on anti-NGF mAb R D. Concentrations in nM (from top): 100, 50, 25, 12.50, 6.25, 3.2, 1.6, 0.8, 0.4, 0.2, 0.1; (E) Different NGF concentrations tested on anti-NGF mAb R D. Concentrations in nM (from top): 100, 50, 25, 12.50, 6.25, 3.2, 1.6, 0.8, 0.4, 0.2, 0.1.

    Journal: Frontiers in Molecular Neuroscience

    Article Title: NGF and proNGF Reciprocal Interference in Immunoassays: Open Questions, Criticalities, and Ways Forward

    doi: 10.3389/fnmol.2016.00063

    Figure Lengend Snippet: SPR analysis—calibration curves obtained with proNGF and NGF over the panel of different antibodies. (A) Different proNGF concentrations tested on anti-proNGF mAb FPro10. Concentrations in nM (from top): 500, 333, 222, 148, 98, 65, 33, 16, 8, 4, 2, 1, 0.5; (B) Different proNGF concentrations tested on anti-proNGF mAb Millipore. Concentrations in nM (from top): 500, 333, 222, 148, 98, 65, 33, 16, 8, 4, 2, 1, 0.5; (C) Different proNGF concentrations tested on anti-NGF mAb αD11. Concentrations in nM (from top): 500, 333, 222, 148, 98, 65, 33, 16, 8, 4, 2, 1, 0.5; (D) Different proNGF concentrations tested on anti-NGF mAb R D. Concentrations in nM (from top): 100, 50, 25, 12.50, 6.25, 3.2, 1.6, 0.8, 0.4, 0.2, 0.1; (E) Different NGF concentrations tested on anti-NGF mAb R D. Concentrations in nM (from top): 100, 50, 25, 12.50, 6.25, 3.2, 1.6, 0.8, 0.4, 0.2, 0.1.

    Article Snippet: A representative WB, challenged both with anti-proNGF and anti-NGF, is shown in Figure .

    Techniques: SPR Assay

    AlphaLISA experiments: curves of NGF, proNGF, mix of NGF + proNGF, comparison at different incubation times . Curves of NGF, proNGF, mix of NGF + proNGF, linearly interpolated. NGF and proNGF were assayed separately and together (dynamic range: 2000–4 pg/ml, 1:2 dilutions, in duplicates), in different stoichiometric ratio. The dilution were done in AlphaLISA NaCl buffer (Perkin Elmer). The protocol is described in the methods sections and called for two incubation times. In (A) the first incubation time lasted 60 min and the second one 30 min, as suggested by the manufacturer's protocol. In (B) , a comparison between different incubation times is shown. The first incubation time was 15, 30, or 60 min, while the second one was 20 min for all the curves. The signal was read on the Perkin Elmer instrument EnVision®.

    Journal: Frontiers in Molecular Neuroscience

    Article Title: NGF and proNGF Reciprocal Interference in Immunoassays: Open Questions, Criticalities, and Ways Forward

    doi: 10.3389/fnmol.2016.00063

    Figure Lengend Snippet: AlphaLISA experiments: curves of NGF, proNGF, mix of NGF + proNGF, comparison at different incubation times . Curves of NGF, proNGF, mix of NGF + proNGF, linearly interpolated. NGF and proNGF were assayed separately and together (dynamic range: 2000–4 pg/ml, 1:2 dilutions, in duplicates), in different stoichiometric ratio. The dilution were done in AlphaLISA NaCl buffer (Perkin Elmer). The protocol is described in the methods sections and called for two incubation times. In (A) the first incubation time lasted 60 min and the second one 30 min, as suggested by the manufacturer's protocol. In (B) , a comparison between different incubation times is shown. The first incubation time was 15, 30, or 60 min, while the second one was 20 min for all the curves. The signal was read on the Perkin Elmer instrument EnVision®.

    Article Snippet: A representative WB, challenged both with anti-proNGF and anti-NGF, is shown in Figure .

    Techniques: Incubation

    NGF and proNGF spiked in the sample buffer (supplied by each supplier of the commercial kits) . The histograms summarize the results of the NGF and proNGF spiked separately and together into the assay buffer of the three different commercial kits for the detection of NGF analyzed. The Promega kit was tested in the two different formats: rat mAb Promega and αD11. Two concentrations of recombinant NGF (10 and 100 pg/ml) and proNGF (50 and 200 pg/ml) were spiked into the assay buffer either alone or together with NGF and measured by using the kits previously described. (A) (Emax Promega with mAb Promega), (B) (Emax Promega with mAb αD11), (C) (Chemikine Chemicon), (D) (NGF Rapid ELISA Biosensis) report the values of concentration, interpolated by the calibration curves. The calculated values of the samples spiked with both NGF and proNGF were compared to the spiked value of only NGF. The t -student test was carried out and the p -values were calculated. Two asterisks on the histograms mean a p

    Journal: Frontiers in Molecular Neuroscience

    Article Title: NGF and proNGF Reciprocal Interference in Immunoassays: Open Questions, Criticalities, and Ways Forward

    doi: 10.3389/fnmol.2016.00063

    Figure Lengend Snippet: NGF and proNGF spiked in the sample buffer (supplied by each supplier of the commercial kits) . The histograms summarize the results of the NGF and proNGF spiked separately and together into the assay buffer of the three different commercial kits for the detection of NGF analyzed. The Promega kit was tested in the two different formats: rat mAb Promega and αD11. Two concentrations of recombinant NGF (10 and 100 pg/ml) and proNGF (50 and 200 pg/ml) were spiked into the assay buffer either alone or together with NGF and measured by using the kits previously described. (A) (Emax Promega with mAb Promega), (B) (Emax Promega with mAb αD11), (C) (Chemikine Chemicon), (D) (NGF Rapid ELISA Biosensis) report the values of concentration, interpolated by the calibration curves. The calculated values of the samples spiked with both NGF and proNGF were compared to the spiked value of only NGF. The t -student test was carried out and the p -values were calculated. Two asterisks on the histograms mean a p

    Article Snippet: A representative WB, challenged both with anti-proNGF and anti-NGF, is shown in Figure .

    Techniques: Recombinant, Enzyme-linked Immunosorbent Assay, Concentration Assay

    ELISA for the differential detection of NGF and ProNGF . (A) Strategy: capture NGF and measure proNGF (Exploiting the mAb αD11 fast kinetics). ELISA sandwiches format based on a pre-capturing of NGF by a treatment of the sample with mAb αD11 (Cattaneo et al., 1988 ) on a solid support. Subsequent detection of proNGF by traditional sandwich ELISA. Antibodies tested in different combinations: Anti-NGF pAb H20 (Santa Cruz no. sc-548), Anti-proNGF scFV FPro10 (Paoletti et al., 2012 ), Anti-NGF pAb M20 (Santa Cruz no. sc-549), Anti-NGF pAb (Sigma no. N 6655), Anti-proNGF pAb (Sigma no. P 5498), mAb αD11 (Cattaneo et al., 1988 ), Anti-NGF mAb 256 (R D no. MAB256). (B) Strategy: capture proNGF and measure proNGF (Exploiting anti—proNGF antibodies in ELISA sandwich). Antibodies tested in different combinations: Anti-proNGF scFV FPro10 (Paoletti et al., 2012 ), mAb αD11 (Cattaneo et al., 1988 ), Anti-NGF pAb M20 (Santa Cruz no. sc-549), Anti-proNGF Novus (no. S-080-100), Anti-NGF mAb 256 (R D no. MAB256), Anti-proNGF mAb (clone EP1318Y) (Millipore no. 04-1142), Anti-proNGF pAb Chemicon (Millipore no. AB9040), Anti-proNGF pAb Alomone (no. ANT-005), Anti-NGF Abnova (no. PAB0755).

    Journal: Frontiers in Molecular Neuroscience

    Article Title: NGF and proNGF Reciprocal Interference in Immunoassays: Open Questions, Criticalities, and Ways Forward

    doi: 10.3389/fnmol.2016.00063

    Figure Lengend Snippet: ELISA for the differential detection of NGF and ProNGF . (A) Strategy: capture NGF and measure proNGF (Exploiting the mAb αD11 fast kinetics). ELISA sandwiches format based on a pre-capturing of NGF by a treatment of the sample with mAb αD11 (Cattaneo et al., 1988 ) on a solid support. Subsequent detection of proNGF by traditional sandwich ELISA. Antibodies tested in different combinations: Anti-NGF pAb H20 (Santa Cruz no. sc-548), Anti-proNGF scFV FPro10 (Paoletti et al., 2012 ), Anti-NGF pAb M20 (Santa Cruz no. sc-549), Anti-NGF pAb (Sigma no. N 6655), Anti-proNGF pAb (Sigma no. P 5498), mAb αD11 (Cattaneo et al., 1988 ), Anti-NGF mAb 256 (R D no. MAB256). (B) Strategy: capture proNGF and measure proNGF (Exploiting anti—proNGF antibodies in ELISA sandwich). Antibodies tested in different combinations: Anti-proNGF scFV FPro10 (Paoletti et al., 2012 ), mAb αD11 (Cattaneo et al., 1988 ), Anti-NGF pAb M20 (Santa Cruz no. sc-549), Anti-proNGF Novus (no. S-080-100), Anti-NGF mAb 256 (R D no. MAB256), Anti-proNGF mAb (clone EP1318Y) (Millipore no. 04-1142), Anti-proNGF pAb Chemicon (Millipore no. AB9040), Anti-proNGF pAb Alomone (no. ANT-005), Anti-NGF Abnova (no. PAB0755).

    Article Snippet: A representative WB, challenged both with anti-proNGF and anti-NGF, is shown in Figure .

    Techniques: Enzyme-linked Immunosorbent Assay, Sandwich ELISA

    Binding analysis of NGF and proNGF mixtures to different antibodies . The following antibodies were immobilized on the chip for SPR experiments. (A) anti-proNGF mAb FPro10; (B) anti-proNGF mAb Millipore; (C) anti-NGF mAb αD11. In all the panels, the curves represent the following analytes from top to bottom: 200 nM proNGF + 20 nM NGF (solid blue line, experimental value); 200 nM proNGF (solid yellow line, experimental value); 200 nM proNGF + 20 nM NGF (segmented blue line, theoretical value); 40 nM proNGF + 20 nM NGF (solid purple line, experimental value); 40 nM proNGF (solid orange line, experimental value); 40 nM proNGF + 20 nM NGF (segmented purple line, theoretical value); 20 nM proNGF + 20 nM NGF (solid green line, experimental value); 20 nM proNGF (solid red line, experimental value); 20 nM proNGF + 20 nM NGF (segmented green line, theoretical value); 20 nM NGF (solid dark blue line, experimental value). The segmented lines represents the theoretical curves for the point-to-point algebraic sum of the experimental curves of the single components, at the concentrations indicated.

    Journal: Frontiers in Molecular Neuroscience

    Article Title: NGF and proNGF Reciprocal Interference in Immunoassays: Open Questions, Criticalities, and Ways Forward

    doi: 10.3389/fnmol.2016.00063

    Figure Lengend Snippet: Binding analysis of NGF and proNGF mixtures to different antibodies . The following antibodies were immobilized on the chip for SPR experiments. (A) anti-proNGF mAb FPro10; (B) anti-proNGF mAb Millipore; (C) anti-NGF mAb αD11. In all the panels, the curves represent the following analytes from top to bottom: 200 nM proNGF + 20 nM NGF (solid blue line, experimental value); 200 nM proNGF (solid yellow line, experimental value); 200 nM proNGF + 20 nM NGF (segmented blue line, theoretical value); 40 nM proNGF + 20 nM NGF (solid purple line, experimental value); 40 nM proNGF (solid orange line, experimental value); 40 nM proNGF + 20 nM NGF (segmented purple line, theoretical value); 20 nM proNGF + 20 nM NGF (solid green line, experimental value); 20 nM proNGF (solid red line, experimental value); 20 nM proNGF + 20 nM NGF (segmented green line, theoretical value); 20 nM NGF (solid dark blue line, experimental value). The segmented lines represents the theoretical curves for the point-to-point algebraic sum of the experimental curves of the single components, at the concentrations indicated.

    Article Snippet: A representative WB, challenged both with anti-proNGF and anti-NGF, is shown in Figure .

    Techniques: Binding Assay, Chromatin Immunoprecipitation, SPR Assay

    IP and WB of transgenic and wild-type mice. (A): IP and WB of cortex extracts from male (M) and female (F) TgProNGF#72 and wild-type (WT) mice. IP on extracts from cortex (CTX) with anti-NGF αD11 antibody, followed by WB with anti-NGF or anti-proNGF antibody, as described in Tiveron et al. ( 2013 ). A representative WB probed with anti-proNGF (PAb Alomone), (top) or anti-NGF M20 (Santa Cruz) (bottom) is shown. TgproNGF#72 and wild type mice, male and female, were analyzed. (B) Quantitative analysis of proNGF and mature NGF in the CTX of TgproNGF#72 mice, male and female, by IP and WB and densitometric analysis. After anti-NGF IP, the proNGF bands, (in WB probed with anti-proNGF), and the NGF bands, (in the WB probed with anti-NGF antibody), both identified also by Mass Spectrometry, were quantified. The resulting intensities were normalized against the area of the bands, and then compared with an internal standard of recombinant proNGF and NGF. Loaded samples were in the linear range of detection. Comparison between proNGF and NGF amounts in TgproNGF#72, male and female, is reported in the histogram. The experiment was carried out in triplicate.

    Journal: Frontiers in Molecular Neuroscience

    Article Title: NGF and proNGF Reciprocal Interference in Immunoassays: Open Questions, Criticalities, and Ways Forward

    doi: 10.3389/fnmol.2016.00063

    Figure Lengend Snippet: IP and WB of transgenic and wild-type mice. (A): IP and WB of cortex extracts from male (M) and female (F) TgProNGF#72 and wild-type (WT) mice. IP on extracts from cortex (CTX) with anti-NGF αD11 antibody, followed by WB with anti-NGF or anti-proNGF antibody, as described in Tiveron et al. ( 2013 ). A representative WB probed with anti-proNGF (PAb Alomone), (top) or anti-NGF M20 (Santa Cruz) (bottom) is shown. TgproNGF#72 and wild type mice, male and female, were analyzed. (B) Quantitative analysis of proNGF and mature NGF in the CTX of TgproNGF#72 mice, male and female, by IP and WB and densitometric analysis. After anti-NGF IP, the proNGF bands, (in WB probed with anti-proNGF), and the NGF bands, (in the WB probed with anti-NGF antibody), both identified also by Mass Spectrometry, were quantified. The resulting intensities were normalized against the area of the bands, and then compared with an internal standard of recombinant proNGF and NGF. Loaded samples were in the linear range of detection. Comparison between proNGF and NGF amounts in TgproNGF#72, male and female, is reported in the histogram. The experiment was carried out in triplicate.

    Article Snippet: A representative WB, challenged both with anti-proNGF and anti-NGF, is shown in Figure .

    Techniques: Western Blot, Transgenic Assay, Mouse Assay, Mass Spectrometry, Recombinant

    Overexpression of proNGF reduced NGF and induced expression of TrkA and p75 NTR , but not sortilin. A , B : Western blot (WB) analysis of rat retinal lysate showed significant (1.5-fold) increase in expression of TrkA and p75 NTR in rats electroporated with pGFP-proNGF123 as compared with those electroporated with pGFP (n=4). C : WB analysis showed that overexpression of pGFP-proNGF123 in rat retinas did not affect sortilin protein expression level as compared with the control rats (n=4). D : WB analysis showed that overexpression of pGFP-proNGF123 significantly reduced NGF expression (n=5) compared with GFP controls. The asterisk represents significant difference as compared with control group at p

    Journal: Molecular Vision

    Article Title: Electroporation-mediated gene delivery of cleavage-resistant pro-nerve growth factor causes retinal neuro- and vascular degeneration

    doi:

    Figure Lengend Snippet: Overexpression of proNGF reduced NGF and induced expression of TrkA and p75 NTR , but not sortilin. A , B : Western blot (WB) analysis of rat retinal lysate showed significant (1.5-fold) increase in expression of TrkA and p75 NTR in rats electroporated with pGFP-proNGF123 as compared with those electroporated with pGFP (n=4). C : WB analysis showed that overexpression of pGFP-proNGF123 in rat retinas did not affect sortilin protein expression level as compared with the control rats (n=4). D : WB analysis showed that overexpression of pGFP-proNGF123 significantly reduced NGF expression (n=5) compared with GFP controls. The asterisk represents significant difference as compared with control group at p

    Article Snippet: Antibodies for proNGF and NGF (Alomone Labs Ltd), p75NTR , sortilin, and TrkA (Millipore) were used.

    Techniques: Over Expression, Expressing, Western Blot